Background The association of incident cardiometabolic multimorbidity (CMM) with mortality
risk is rarely studied, and neither are the durations of cardiometabolic diseases (CMDs) …

Importance The prevalence of cardiometabolic multimorbidity is increasing. Objective To
estimate reductions in life expectancy associated with cardiometabolic multimorbidity …

Aims The potential difference in the impacts of lifestyle factors (LFs) on progression from
healthy to first cardiometabolic disease (FCMD), subsequently to cardiometabolic …

Background: The prevalence of cardiometabolic multimorbidity, which significantly increases
the risk of mortality, is increasing globally. However, the role of healthy lifestyle in the …

Objectives The evolution of multimorbidity describes the continuum from a healthy status to
the development of a single disease and further progression to multimorbidity with additional …

Background and aims Cardiometabolic multimorbidity has become increasingly common
over the past few decades. Little is known about how risk factors affect temporal progression …

Several prospective cohort studies have assessed the association between multimorbidity
and all-cause mortality, but the findings have been inconsistent. In addition, limited studies …

Context Diabetes, hypertension and dyslipidemia accelerates the incidence of
cardiovascular disease (CVD) events. However, data regarding the association between …

Aims To examine the long-term influence of metabolic syndrome (MetS) on death and
vascular complications. Methods Altogether, 1419 individuals with different levels of …

Background Myocardial infarction (MI), stroke and diabetes share underlying risk factors and
commonalities in clinical management. We examined if their combined impact on mortality is …